Arterial endothelial function is impaired in treated depression
暂无分享,去创建一个
C. Jones | M. Frenneaux | A. Korszun | A. Broadley | A J M Broadley | A Korszun | C J H Jones | M P Frenneaux | C. Jones | Ania Korszun | Andrew J.M. Broadley | Christopher J.H. Jones | Michael P. Frenneaux
[1] B. Pollock,et al. Paroxetine is a novel nitric oxide synthase inhibitor. , 1996, Psychopharmacology bulletin.
[2] C. Nemeroff,et al. Exaggerated platelet reactivity in major depression. , 1996, The American journal of psychiatry.
[3] C. Jones,et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. , 1995, Circulation.
[4] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[5] R. Hughson,et al. Spontaneous cardiac baroreflex in humans. Comparison with drug-induced responses. , 1995, Hypertension.
[6] C. Tangen,et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. , 2000, Circulation.
[7] Octavio Gómez Dantés,et al. The World Health Report 1999. Making a Difference , 1999 .
[8] D. Ford,et al. Depression is a risk factor for coronary artery disease in men: the precursors study. , 1998, Archives of internal medicine.
[9] M. Moeschberger,et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. , 2000, Archives of internal medicine.
[10] R. Crum,et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. , 1996, Circulation.
[11] C. Nemeroff,et al. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.
[12] A. Steptoe,et al. Mental Stress Induces Transient Endothelial Dysfunction in Humans , 2000, Circulation.
[13] E. H. Reynolds,et al. Enhancement of recovery from psychiatric illness by methylfolate , 1990, The Lancet.
[14] M. Schroll,et al. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. , 1996, Circulation.
[15] M. Rubenfire,et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.
[16] N. Frasure-smith,et al. Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.
[17] C. Pope,et al. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. , 1994, American journal of public health.
[18] J. Bigger,et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.
[19] B. Toone,et al. Enhancement of recovery from psychiatric illness by methylfolate , 1992, British Journal of Psychiatry.
[20] D. Webb,et al. Cortisol inhibits cholinergic vasodilation in the human forearm. , 2000, American journal of hypertension.
[21] R. Cannon,et al. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women. , 2000, Journal of the American College of Cardiology.
[22] P. Grossman,et al. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. , 1999, American heart journal.
[23] E. Eaker,et al. Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.
[24] C. Tangen,et al. Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans , 2000 .